PL2691119T3 - Preparat farmaceutyczny - Google Patents
Preparat farmaceutycznyInfo
- Publication number
- PL2691119T3 PL2691119T3 PL12719996T PL12719996T PL2691119T3 PL 2691119 T3 PL2691119 T3 PL 2691119T3 PL 12719996 T PL12719996 T PL 12719996T PL 12719996 T PL12719996 T PL 12719996T PL 2691119 T3 PL2691119 T3 PL 2691119T3
- Authority
- PL
- Poland
- Prior art keywords
- pharmaceutical preparation
- pharmaceutical
- preparation
- Prior art date
Links
- 239000000825 pharmaceutical preparation Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
- A61K47/60—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes the organic macromolecular compound being a polyoxyalkylene oligomer, polymer or dendrimer, e.g. PEG, PPG, PEO or polyglycerol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/10—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Endocrinology (AREA)
- Epidemiology (AREA)
- Reproductive Health (AREA)
- Pregnancy & Childbirth (AREA)
- Gynecology & Obstetrics (AREA)
- Diabetes (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Peptides Or Proteins (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP11160736 | 2011-03-31 | ||
| EP12151389 | 2012-01-17 | ||
| EP12719996.6A EP2691119B1 (en) | 2011-03-31 | 2012-03-29 | Pharmaceutical preparation |
| PCT/GB2012/000291 WO2012131306A1 (en) | 2011-03-31 | 2012-03-29 | Pharmaceutical preparation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL2691119T3 true PL2691119T3 (pl) | 2019-01-31 |
Family
ID=46051700
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL12719996T PL2691119T3 (pl) | 2011-03-31 | 2012-03-29 | Preparat farmaceutyczny |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US9757469B2 (pl) |
| EP (1) | EP2691119B1 (pl) |
| JP (2) | JP6087338B2 (pl) |
| CN (1) | CN103619358B (pl) |
| CA (2) | CA3163525A1 (pl) |
| ES (1) | ES2693273T3 (pl) |
| PL (1) | PL2691119T3 (pl) |
| WO (1) | WO2012131306A1 (pl) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI488640B (zh) | 2008-04-16 | 2015-06-21 | 菲瑞茵國際中心股份有限公司 | 藥學製劑 |
| TWI532495B (zh) * | 2009-10-05 | 2016-05-11 | 菲瑞茵國際中心股份有限公司 | 藥學製劑 |
| CN103619358B (zh) * | 2011-03-31 | 2017-02-15 | 辉凌公司 | 药物制剂 |
| US20220267401A1 (en) * | 2016-03-22 | 2022-08-25 | Universidade De São Paulo - Usp | Method for producing and purifying hybrid or non-hybrid recombinant glycoprotein hormones, hybrid or non-hybrid recombinant glycoprotein hormones, expression vectors and uses of the recombinant glycoprotein hormones |
Family Cites Families (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4179337A (en) * | 1973-07-20 | 1979-12-18 | Davis Frank F | Non-immunogenic polypeptides |
| US4421896A (en) * | 1979-11-13 | 1983-12-20 | The Dow Chemical Company | Method of coupling a protein to a polymer particle containing hydrazide groups in a polymer latex and the products formed therefrom |
| DK49987A (da) | 1987-01-30 | 1988-07-31 | Nordisk Gentofte | Fremgangsmaade til behandling af infertilitet og middel til anvendelse ved fremgangsmaaden |
| IT1206302B (it) | 1987-06-26 | 1989-04-14 | Serono Cesare Ist Ricerca | Ormone follicolo-stimolante urinario |
| TW518235B (en) | 1997-01-15 | 2003-01-21 | Akzo Nobel Nv | A gonadotropin-containing pharmaceutical composition with improved stability on prolong storage |
| CN100404551C (zh) | 1997-06-25 | 2008-07-23 | 雪兰诺实验室有限公司 | 二硫键交联的糖蛋白激素类似物及其制备和应用 |
| US6500627B1 (en) | 1998-02-03 | 2002-12-31 | The Trustees Of Columbia University In The City Of New York | Methods for predicting pregnancy outcome in a subject by HCG assay |
| US7297777B2 (en) | 2000-02-22 | 2007-11-20 | Laboratoires Serono Sa | Process of purification of hCG and recombinant hCG purified by that method |
| WO2003022302A2 (en) | 2001-09-12 | 2003-03-20 | Applied Research Systems Ars Holding N.V. | USE OF hCG IN CONTROLLED OVARIAN HYPERSTIMULATION |
| JP2005515974A (ja) | 2001-10-22 | 2005-06-02 | アプライド リサーチ システムズ エーアールエス ホールディング ナームロゼ フェンノートシャップ | 卵胞形成のためのゴナドドロピン |
| EA008220B1 (ru) | 2001-10-29 | 2007-04-27 | Круселл Холланд Б.В. | Композиция, включающая эритропоэтинподобные молекулы, и способы ее применения |
| US20040248784A1 (en) * | 2003-06-03 | 2004-12-09 | Marco Filicori | Unitary combinations of FSH and hCG |
| ATE476666T1 (de) | 2004-02-04 | 2010-08-15 | Centre Nat Rech Scient | Verfahren zur identifizierung von glykoformspezifischen antikörpern |
| US8609370B2 (en) | 2004-02-13 | 2013-12-17 | Glycotope Gmbh | Highly active glycoproteins-process conditions and an efficient method for their production |
| US9187532B2 (en) * | 2006-07-21 | 2015-11-17 | Novo Nordisk A/S | Glycosylation of peptides via O-linked glycosylation sequences |
| CA2665480C (en) * | 2006-10-04 | 2019-11-12 | Novo Nordisk A/S | Glycerol linked pegylated sugars and glycopeptides |
| WO2009089396A2 (en) * | 2008-01-08 | 2009-07-16 | Neose Technologies, Inc. | Glycoconjugation of polypeptides using oligosaccharyltransferases |
| TWI488640B (zh) | 2008-04-16 | 2015-06-21 | 菲瑞茵國際中心股份有限公司 | 藥學製劑 |
| TWI532495B (zh) | 2009-10-05 | 2016-05-11 | 菲瑞茵國際中心股份有限公司 | 藥學製劑 |
| CN103619358B (zh) * | 2011-03-31 | 2017-02-15 | 辉凌公司 | 药物制剂 |
-
2012
- 2012-03-29 CN CN201280026567.5A patent/CN103619358B/zh not_active Expired - Fee Related
- 2012-03-29 US US14/008,067 patent/US9757469B2/en not_active Expired - Fee Related
- 2012-03-29 CA CA3163525A patent/CA3163525A1/en active Pending
- 2012-03-29 PL PL12719996T patent/PL2691119T3/pl unknown
- 2012-03-29 EP EP12719996.6A patent/EP2691119B1/en active Active
- 2012-03-29 JP JP2014501706A patent/JP6087338B2/ja not_active Expired - Fee Related
- 2012-03-29 WO PCT/GB2012/000291 patent/WO2012131306A1/en not_active Ceased
- 2012-03-29 ES ES12719996.6T patent/ES2693273T3/es active Active
- 2012-03-29 CA CA2831486A patent/CA2831486A1/en not_active Abandoned
-
2016
- 2016-12-08 JP JP2016238126A patent/JP6336557B2/ja not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| ES2693273T3 (es) | 2018-12-10 |
| CN103619358B (zh) | 2017-02-15 |
| US20140088010A1 (en) | 2014-03-27 |
| JP2014510745A (ja) | 2014-05-01 |
| CA3163525A1 (en) | 2012-10-04 |
| WO2012131306A1 (en) | 2012-10-04 |
| JP2017101030A (ja) | 2017-06-08 |
| JP6087338B2 (ja) | 2017-03-01 |
| EP2691119B1 (en) | 2018-08-01 |
| WO2012131306A8 (en) | 2013-10-24 |
| EP2691119A1 (en) | 2014-02-05 |
| CA2831486A1 (en) | 2012-10-04 |
| JP6336557B2 (ja) | 2018-06-06 |
| CN103619358A (zh) | 2014-03-05 |
| US9757469B2 (en) | 2017-09-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AP3864A (en) | Pharmaceutical composition | |
| SI2776416T1 (sl) | Farmacevtske spojine | |
| SG10201604667YA (en) | Pharmaceutical preparation | |
| ZA201307372B (en) | Coated solid pharmaceutical preparation | |
| GB201118232D0 (en) | Pharmaceutical composition | |
| AP2014007498A0 (en) | Pharmaceutical compositions | |
| IL232305B (en) | Pharmacy preparations | |
| ZA201308157B (en) | Pharmaceutical composition | |
| GB201119799D0 (en) | Pharmaceutical compounds | |
| ZA201403832B (en) | Pharmaceutical compounds | |
| GB201105298D0 (en) | Pharmaceutical preparation | |
| GB201118876D0 (en) | Pharmaceutical compounds | |
| GB201113163D0 (en) | Pharmaceutical compounds | |
| EP2727593A4 (en) | PHARMACEUTICAL COMPOSITION CONTAINING NICORANDIL | |
| PL2691119T3 (pl) | Preparat farmaceutyczny | |
| EP2711010A4 (en) | PHARMACEUTICAL COMPOSITION | |
| HUP1100444A2 (en) | Pharmaceutical composition | |
| HUP1100445A2 (en) | Pharmaceutical composition | |
| GB201119796D0 (en) | Pharmaceutical comopounds | |
| GB201120735D0 (en) | New pharmaceutical uses | |
| GB201111577D0 (en) | Pharmaceutical formulations | |
| ZA201309537B (en) | Pharmaceutical composition comprising fexofedine | |
| PL390620A1 (pl) | Preparat farmaceutyczny | |
| GB201118874D0 (en) | Pharmaceutical compounds | |
| GB201118875D0 (en) | Pharmaceutical compounds |